M. Cabeza-Segura

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma

N. Tarazona, S. Roselló, M. Huerta, 2022, British Journal of Cancer.

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”

F. Papaccio, N. Tarazona, C. Alfaro-Cervelló, 2023, Journal of Experimental & Clinical Cancer Research.

The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.

A. Cervantes, N. Tarazona, S. Roselló, 2020, Cancer treatment reviews.

How organoids can improve personalized treatment in patients with gastro-esophageal tumors.

F. Papaccio, V. Conti, A. Filippelli, 2023, Current opinion in pharmacology.

Will Organoids Fill the Gap towards Functional Precision Medicine?

F. Papaccio, N. Tarazona, D. Roda, 2022, Journal of personalized medicine.

In the literature: December 2021

C. Montagut, V. Gambardella, A. Cervantes, 2021, ESMO open.